Caverta is a prescription medication specifically formulated to address erectile dysfunction (ED) in adult men. It contains the active ingredient Sildenafil Citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor that works by increasing blood flow to the penis, facilitating the achievement and maintenance of an erection sufficient for sexual activity. This medication is intended for use only when sexual stimulation occurs and is not an aphrodisiac or hormone. Clinical studies and real-world usage have established its efficacy and safety profile when used as directed under medical supervision. Caverta represents a reliable therapeutic option for men seeking to restore sexual function and improve quality of life.

Features

• Active ingredient: Sildenafil Citrate
• Available in 25 mg, 50 mg, and 100 mg film-coated tablets
• Rapid onset of action, typically within 30–60 minutes
• Duration of effect up to 4–6 hours
• Requires sexual stimulation for efficacy
• Manufactured under strict quality control standards

Benefits

• Enables reliable achievement and maintenance of erections suitable for sexual intercourse
• Improves sexual confidence and reduces performance anxiety
• Enhances overall sexual satisfaction for both partners
• Supports spontaneous sexual activity within the medication’s effective window
• Non-hormonal mechanism of action with no effect on libido
• Well-established safety profile with extensive clinical data

Common use

Caverta is primarily prescribed for the treatment of erectile dysfunction, characterized by the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It is used by adult men across various age groups, particularly those with organic, psychogenic, or mixed etiology ED. The medication is commonly utilized by individuals with underlying conditions such as diabetes, hypertension, or cardiovascular disease where erectile dysfunction may present as a comorbid condition. It is important to note that Caverta does not protect against sexually transmitted diseases or serve as a form of contraception.

Dosage and direction

The recommended starting dose is 50 mg taken approximately one hour before anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. Tablets should be swallowed whole with a glass of water and may be taken with or without food, though high-fat meals may delay onset of action. Sexual stimulation is required for the medication to be effective. Do not crush, break, or chew the tablets.

Precautions

Prior to using Caverta, patients should undergo a thorough medical evaluation to assess cardiovascular status, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, bleeding disorders, or active peptic ulceration. Caverta may cause hypotension; particular caution is advised in patients with left ventricular outflow obstruction. Patients should avoid excessive alcohol consumption while taking this medication. Regular follow-up with a healthcare provider is recommended to monitor treatment response and potential adverse effects.

Contraindications

Caverta is contraindicated in patients taking any form of organic nitrates or nitric oxide donors, either regularly or intermittently, due to the risk of profound hypotension. Additional contraindications include hypersensitivity to Sildenafil or any component of the formulation, severe hepatic impairment, severe hypotension, recent stroke or myocardial infarction, and unstable angina. The medication is not indicated for use in women, children, or adolescents under 18 years of age.

Possible side effects

Common side effects include headache, flushing, dyspepsia, nasal congestion, and visual disturbances such as altered color perception. Less frequently reported effects include dizziness, rash, and musculoskeletal pain. Rare but serious adverse effects include priapism (prolonged erection lasting more than 4 hours), sudden hearing loss, sudden vision loss, and cardiovascular events. Patients experiencing any severe or persistent side effects should seek immediate medical attention.

Drug interaction

Concomitant use with nitrates is absolutely contraindicated. Caverta may potentiate the hypotensive effects of alpha-blockers. CYP3A4 inhibitors (such as ketoconazole, ritonavir, erythromycin) may increase Sildenafil concentrations, requiring dose adjustment. Inducers of CYP3A4 may decrease Sildenafil concentrations. Grapefruit juice may increase plasma concentrations of Sildenafil and should be avoided. Caverta may potentiate the blood pressure-lowering effects of antihypertensive medications.

Missed dose

Caverta is not intended for regular scheduled dosing but is taken as needed prior to sexual activity. There is no concern regarding missed doses as the medication is not administered on a fixed schedule. If a dose is not taken at the planned time, it may be taken later when needed, provided the maximum once-daily dosing frequency is not exceeded.

Overdose

In cases of suspected overdose, standard supportive measures should be employed. Expected effects would be consistent with Sildenafil’s vasodilatory properties and may include severe hypotension, syncope, and prolonged erection. Hemodynamic support may be required for significant hypotension. Priapism requires immediate urological intervention to prevent permanent tissue damage. Dialysis is not expected to enhance elimination as Sildenafil is highly protein-bound.

Storage

Store at room temperature (15–30°C) in the original packaging to protect from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly dispose of any unused medication according to local regulations, not via household waste or wastewater.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Caverta is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients should not initiate or modify treatment without consulting their physician. Individual response to medication may vary, and not all potential interactions or side effects are listed here.

Reviews

Clinical studies demonstrate that Caverta significantly improves erectile function in men with erectile dysfunction across various etiologies. In randomized controlled trials, approximately 80% of patients reported improved erections compared to 20% receiving placebo. Real-world evidence supports sustained efficacy with appropriate use, though individual responses may vary based on underlying health conditions, psychological factors, and proper dosing. Patient satisfaction surveys indicate high levels of improvement in sexual confidence and relationship satisfaction when used as part of a comprehensive approach to sexual health.